Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Razzberry was a private U.S. health technology company focused on wearable electrochemical microsensors for non-invasive sweat analysis. The company developed printed, postage-stamp-sized sensors intended to measure sweat analytes in real time, including electrolytes, heavy metals, and toxins, with potential applications in personalized health monitoring and diagnostics. Its technology appears to have been positioned as both a hardware sensing platform and a future data platform for continuous health tracking. Public company-profile sources indicate the business was founded in 2014, based in Berkeley, California, and is now permanently closed. Razzberry does not appear to have advanced a traditional therapeutic drug pipeline; instead, it operated in biosensing and digital health/diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Razzberry.